Loading clinical trials...
Loading clinical trials...
Phase II Study of Autologous Lymphocyte Infusions After Radiation Therapy to Mitigate Radiation Induced Lymphopenia and Enhance Immune Reconstitution in Patients With Solid Tumor Malignancies
Conditions
Interventions
Autologous lymphocyte infusion (ALI)
Locations
1
United States
M D Anderson Cancer Center
Houston, Texas, United States
Start Date
September 29, 2020
Primary Completion Date
October 24, 2025
Completion Date
October 24, 2025
Last Updated
October 31, 2025
NCT07299747
NCT07128914
NCT07231120
NCT07264803
NCT06883539
NCT07303387
Lead Sponsor
M.D. Anderson Cancer Center
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions